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Abstract—Glioblastoma cells can evade 
TRAIL-induced apoptosis through 
various strategies involving the growth 
factor-activated MEK–MAPK/ERK 
and PI3K–Akt/PKB pro-survival 
signalling cascades. Although these 
signalling cascades have been studied 
extensively, our understanding of how 
they interact and participate in 
modulating apoptosis as part of a 
dynamic cell-wide network of signalling 
proteins is limited by traditional 
univariate experimental paradigms. 
Here, we study three human 
glioblastoma cell lines with differential 
response to TRAIL-induced apoptosis: 
LN229 (resistant), T98G, and A172 
(both susceptible). We show that 
differential TRAIL susceptibility in 
these cell lines is unrelated to expression 
levels of agonist (DR4 and DR5) or 
antagonist (DcR1, DcR2, and OPG) 
receptors for TRAIL and thus TRAIL-
induced apoptosis in these cell lines is 
modulated at the intracellular signalling 
level. Serum, comprising multiple 
factors that regulate cellular activity, 
enhances TRAIL resistance in T98G 
but not LN229 and A172 cell lines. This 
protective effect against TRAIL-
induced apoptosis is recapitulated by 
the prototypical survival factor PDGF 
in T98G cells. Univariate inhibition of 
cell survival signalling cascades with 
MEK inhibitor U0126 and PI3K 
inhibitor LY294002 sensitized T98G 
cells to TRAIL but did not abrogate 
PDGF-mediated protection. However, 
further perturbation with inhibitors in 
a combinatorial and multivariate 
manner reveal synergistic effects and 
complex systemic responses which may 
be a basis for uncovering novel insights 
into the regulation of TRAIL-induced 
apoptosis. 
